基于SEER的风险分层系统用于原发性非肝硬化性肝癌患者
Runmin Cao1, Honghe Jiang2, Guangpeng Liang1
1Graduate School, Jinzhou Medical University Postgraduate Training Base (Jinzhou Central Hospital), Jinzhou City, Liaoning Province, China.
Journal of cancer research and clinical oncology
|July 8, 2023
概括
一种新的诺米图准确地预测了非肝硬化性肝细胞癌 (HCC-NCL) 患者的整体存活率,其表现优于AJCC分期系统. 这个工具有助于个性化治疗和管理HCC-NCL患者.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 癌症预后 癌症预后
- 生物统计学 生物统计学
背景情况:
- 关于非肝硬化肝细胞癌 (HCC-NCL) 的预后因素的研究有限.
- 准确的生存预测对于HCC-NCL患者的有效管理至关重要.
研究的目的:
- 开发和验证用于预测HCC-NCL患者的整体存活期 (OS) 的名图.
- 为HCC-NCL建立一个新的风险分层系统.
- 为了与AJCC分阶段系统对比名图的预后准确度.
主要方法:
- 对HCC-NCL患者的SEER数据库 (2010-2019) 的回顾性分析.
- 在培训/验证集上使用COX回归分析开发名图.
- 通过ROC,DCA,校准曲线,C指数,NRI和IDI评估诺米克图的准确性和临床效用.
- 与使用卡普兰-梅尔曲线的AJCC分期进行比较.
主要成果:
- 确定了AFP水平,手术干预,T期,瘤大小和M期作为独立的预后指标.
- 开发的名图表显示出高精度和临床有效性.
- 与AJCC分期系统相比,名图显示出更高的预后准确性.
结论:
- 为HCC-NCL患者开发了一种经过验证的名谱,其中包含了风险分层.
- 诺米图提供了个性化的治疗和管理策略.
- 这种工具比目前的AJCC分期系统提供了更好的预测能力.
相关概念视频
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


